MYCT1 and acute myeloid leukemia: Next, to explore the correlation between MYCT1 expression and AML clinical characteristics, AML patients were divided into two groups: the low MYCT1 group (n = 25, fold-change ≥ median), and the high MYCT1 group (n = 25, fold-change ≤ median).